CAS 320337-48-2

Lapatinib Impurity 8

CAS: 320337-48-2

Formel: C₂₆H₁₉ClFN₃O₃

Farbe und Form: Yellow Solid

Molekulargewicht: 475.90

Ref: 4Z-L-259

Des(sulfonylethyl)amino Hydroxy Lapatinib

Kontrolliertes Produkt

CAS: 320337-48-2

Applications Des(sulfonylethyl)amino Hydroxy Lapatinib is a compound related to drug Lapatinib (L175808), which is a selective inhibitor of epidermal growth factor receptor (EGFR) and HER-2 tyrosine kinases. Lapatinib is used to treat breast cancer, especially metastatic breast cancer that has progressed after trastuzumab treatment and other chemotherapy.
References Konecny, G., et al.: Cancer Res., 66, 1630 (2006); Geyer, C., et al.: N. Engl. J. Med., 355, 2733 (2006);

Formel: C₂₆H₁₉ClFN₃O₃

Farbe und Form: Neat

Molekulargewicht: 475.9

Ref: TR-D297423

Des(sulfonylethyl)amino hydroxy lapatinib

CAS: 320337-48-2

Lapatinib is a potent and selective small molecule that inhibits the tyrosine kinase activity of epidermal growth factor receptors (EGFR) and the related receptor tyrosine kinases, HER2/neu. The drug is used in research to study protein interactions with ligands and receptors, and as an inhibitor in pharmacological studies. Lapatinib binds to the ATP binding site of EGFR, preventing its activation by binding to peptide ligands or antibodies. It also binds to the ATP binding site of HER2/neu, preventing its activation by binding to peptide ligands or antibodies. Lapatinib also binds to G-protein coupled receptors (GPCRs), but does not inhibit their activity.

Formel: C₂₆H₁₉ClFN₃O₃

Reinheit: Min. 95%

Molekulargewicht: 475.90 g/mol

Ref: 3D-VMA33748

Lapatinib Impurity 4

CAS: 320337-48-2

Formel: C₂₆H₁₉ClFN₃O₃

Molekulargewicht: 475.9

Ref: ST-EA-CP-L46006